Is Cue Biopharma, Inc. (CUE) a Buy, Sell, or Hold?
NASDAQ : CUE
Cue Biopharma, Inc. — Analyst Ratings
$26.84 USD
-$3.56 (-11.71%)
- Volume
- 474.88K
- Average Volume
- 503.74K
- Market Capitalization
- $70.53M
- P/E Ratio
- -4.86
- Dividend Yield
- 0.00%
- Price Target
- $4.00
- Year High
- $45.50
- Year Low
- $4.98
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.57
Analyst Consensus Summary
Consensus Rating
Sell
9 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
571.0%
vs Current Price
Price Target
$4.00
Average TargetPrice Target Range
Lowest Target
$2.00
1242.0% UPSIDE
Average Target
$4.00
Median Estimate
Highest Target
$7.00
283.4% UPSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 9
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 9 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Jefferies | Maury Raycroft | $4 | $1.285 | 2024-11-15 08:59 AM | 211.3% |
| JMP Securities | Reni Benjamin | $2 | $0.7033 | 2024-07-26 02:14 AM | 184.4% |
| Jefferies | Maury Raycroft | $6 | $2.15 | 2024-03-12 10:52 PM | 179.1% |
| Piper Sandler | Edward Tenthoff | $7 | $3.22 | 2022-11-20 01:23 PM | 117.4% |